Episode 125: AML Series, Pt 11 - Treatment of patients unfit for intensive therapy
The Fellow on Call: The Heme/Onc Podcast
The Evolution of AML Treatment for Less Fit Patients
This chapter examines the treatment evolution for patients with acute myeloid leukemia who are not candidates for intensive therapy. It covers a case study on IDH1 mutated AML and reviews the shift from traditional chemotherapy to modern lower-dose therapies, highlighting significant studies that have influenced current practices.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
